Burkin M A, Sviridov V V, Perelygina O V
Prikl Biokhim Mikrobiol. 2004 Jul-Aug;40(4):478-84.
The procedure of obtaining monoclonal antibodies TT-1, TT-2, and TT-3 against tetanus toxin/toxoid is described. It is shown that both commercial DTP vaccine and tetanus toxoid conjugated with a low-molecular-weight hapten can be used an immunogens. Monoclonal antibodies TT-1 and TT-2 neutralized tetanus toxin in vivo. The monoclonal antibodies obtained were used to design and compare several schemes of quantitative determination of tetanus toxoid and toxin by ELISA. A more sensitive competitive ELISA allowed detecting as much as 0.01 EC/ml toxoid and 50 LD50/ml toxin.
描述了获得抗破伤风毒素/类毒素的单克隆抗体TT-1、TT-2和TT-3的过程。结果表明,市售的百白破疫苗和与低分子量半抗原偶联的破伤风类毒素均可用作免疫原。单克隆抗体TT-1和TT-2在体内可中和破伤风毒素。所获得的单克隆抗体用于设计和比较几种通过酶联免疫吸附测定法(ELISA)定量测定破伤风类毒素和毒素的方案。一种更灵敏的竞争性ELISA能够检测低至0.01 EC/ml的类毒素和50 LD50/ml的毒素。